Annukka M. Kivelä

Annukka M. Kivelä

Auto-generated profile, based on publicly available information

Annukka M. Kivelä

A 1 University of Eastern Finland, A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine , Kuopio, Finland +358 403 552 075 ;

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
HJHenna-Kaisa JyrkkänEn
Henna-Kaisa JyrkkänEn
EKEmilia Kansanen
Emilia Kansanen
MIMatias Inkala
Matias Inkala
AKAnnukka M. Kivelä
Annukka M. Kivelä
HHHanna Hurttila
Hanna Hurttila
ALAnna-liisa Levonen
Anna-liisa Levonen
Besides their well-characterized proinflammatory and proatherogenic effects, oxidized phospholipids, such as oxPAPC (oxidized 1-palmitoyl-2-arachidonoyl- sn -glycero-phosphocholine) have been shown to have beneficial responses in vascular cells via induction of antioxidant enzymes such as heme oxygenase-1. We therefore hypothesized that oxPAPC could evoke a general cytoprotective response via activation of antioxidative transcription factor Nrf2. Here, we show that oxPAPC increases nuclear accumulation of Nrf2. Using the small interfering RNA approach, we demonstrate that Nrf2 is critical in mediating the induction of glutamate-cysteine ligase modifier subunit (GCLM) and NAD(P)H quinone oxidoreductase-1 (NQO1) by oxPAPC in human endothelial cells, whereas the contribution to the induction of heme oxygenase-1 was less significant. The induction of GCLM and NQO1 was attenuated by reduction of electrophilic groups with sodium borohydrate, as well as treatment with thiol antioxidant N -acetylcysteine, suggesting that the thiol reactivity of oxPAPC is largely mediating its effect on Nrf2-responsive genes. Moreover, we show that oxidized phospholipid having a highly electrophilic isoprostane ring in its sn-2 position is a potent inducer of Nrf2 target genes. Finally, we demonstrate that the oxPAPC-inducible expression of heme oxygenase-1, GCLM, and NQO1 is lower in Nrf2-null than wild-type mouse carotid arteries in vivo. We suggest that the activation of Nrf2 by oxidized phospholipids provides a mechanism by which their deleterious effects are limited in the vasculature.

1 November 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
EKEmilia Kansanen
Emilia Kansanen
HJHenna-Kaisa Jyrkkänen
Henna-Kaisa Jyrkkänen
OVOscar L. Volger
Oscar L. Volger
HLHanna Leinonen
Hanna Leinonen
AKAnnukka M. Kivelä
Annukka M. Kivelä
ALAnna-liisa Levonen
Anna-liisa Levonen
Electrophilic fatty acid derivatives, including nitrolinoleic acid and nitro-oleic acid (OA-NO(2)), can mediate anti-inflammatory and pro-survival signaling reactions. The transcription factor Nrf2, activated by electrophilic fatty acids, suppresses redox-sensitive pro-inflammatory gene expression and protects against vascular endothelial oxidative injury. It was therefore postulated that activation of Nrf2 by OA-NO(2) accounts in part for its anti-inflammatory actions, motivating the characterization of Nrf2-dependent and -independent effects of OA-NO(2) on gene expression using genome-wide transcriptional profiling. Control and Nrf2-small interfering RNA-transfected human endothelial cells were treated with vehicle, oleic acid, or OA-NO(2), and differential gene expression profiles were determined. Although OA-NO(2) significantly induced the expression of Nrf2-dependent genes, including heme oxygenase-1 and glutamate-cysteine ligase modifier subunit, the majority of OA-NO(2)-regulated genes were regulated by Nrf2-independent pathways. Moreover, gene set enrichment analysis revealed that the heat shock response is the major pathway activated by OA-NO(2), with robust induction of a number of heat shock genes regulated by the heat shock transcription factor. Inasmuch as the heat shock response mediates anti-inflammatory and cytoprotective actions, this mechanism is proposed to contribute to the protective cell signaling functions of nitro-fatty acids and other electrophilic fatty acid derivatives.

1 November 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
EKEmilia Kansanen
Emilia Kansanen
AKAnnukka M. Kivelä
Annukka M. Kivelä
ALAnna-liisa Levonen
Anna-liisa Levonen

28 October 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MKMinna U Kaikkonen
Minna U Kaikkonen
HNHenri Niskanen
Henri Niskanen
CRCasey E. Romanoski
Casey E. Romanoski
EKEmilia Kansanen
Emilia Kansanen
AKAnnukka M. Kivelä
Annukka M. Kivelä
Seppo Ylä-HerttualaSeppo Ylä-Herttuala
Seppo Ylä-Herttuala
Vascular endothelial growth factor A (VEGF-A) is a master regulator of angiogenesis, vascular development and function. In this study we investigated the transcriptional regulation of VEGF-A-responsive genes in primary human aortic endothelial cells (HAECs) and human umbilical vein endothelial cells (HUVECs) using genome-wide global run-on sequencing (GRO-Seq). We demonstrate that half of VEGF-A-regulated gene promoters are characterized by a transcriptionally competent paused RNA polymerase II (Pol II). We show that transition into productive elongation is a major mechanism of gene activation of virtually all VEGF-regulated genes, whereas only ∼40% of the genes are induced at the level of initiation. In addition, we report a comprehensive chromatin interaction map generated in HUVECs using tethered conformation capture (TCC) and characterize chromatin interactions in relation to transcriptional activity. We demonstrate that sites of active transcription are more likely to engage in chromatin looping and cell type-specific transcriptional activity reflects the boundaries of chromatin interactions. Furthermore, we identify large chromatin compartments with a tendency to be coordinately transcribed upon VEGF-A stimulation. We provide evidence that these compartments are enriched for clusters of regulatory regions such as super-enhancers and for disease-associated single nucleotide polymorphisms (SNPs). Collectively, these findings provide new insights into mechanisms behind VEGF-A-regulated transcriptional programs in endothelial cells.

10 June 2013 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
SHSuvi E. Heinonen
Suvi E. Heinonen
AKAnnukka M. Kivelä
Annukka M. Kivelä
JHJenni Huusko
Jenni Huusko
MDMarike H. Dijkstra
Marike H. Dijkstra
EGErika Gurzeler
Erika Gurzeler
Seppo Ylä-HerttualaSeppo Ylä-Herttuala
Seppo Ylä-Herttuala
The role of vascular endothelial growth factor (VEGF-A) in atherogenesis has remained controversial. We addressed this by comparing the effects of adenoviral VEGF-A gene transfer on atherosclerosis and lipoproteins in ApoE−/−, LDLR−/−, LDLR−/−ApoE−/−, and LDLR−/−ApoB100/100 mice. After 4 weeks on western diet, systemic adenoviral gene transfer was performed with hVEGF-A or control vectors. Effects on atherosclerotic lesion area and composition, lipoprotein profiles, and plasma lipoprotein lipase (LPL) activity were examined. On day 4, VEGF-A induced alterations in lipoprotein profiles and a significant negative correlation was observed between plasma LPL activity and VEGF-A levels. One month after gene transfer, no changes in atherosclerosis were observed in LDLR−/− and LDLR−/−ApoB100/100 models, whereas both ApoE−/− models displayed increased en face lesion areas in thoracic and abdominal aortas. VEGF-A also reduced LPL mRNA in heart and white adipose tissue, whereas Angptl4 was increased, potentially providing further mechanistic explanation for the findings. VEGF-A gene transfer induced pro-atherogenic changes in lipoprotein profiles in all models. As a novel finding, VEGF-A also reduced LPL activity, which might underlie the observed changes in lipid profiles. However, VEGF-A was observed to increase atherosclerosis only in the ApoE−/− background, clearly indicating some mouse model-specific effects.

1 May 2008 in Gene Therapy
Verified
Journal Article
Closed access
HHH Hurttila
H Hurttila
JKJ K Koponen
J K Koponen
EKE Kansanen
E Kansanen
HJH-K Jyrkkänen
H-K Jyrkkänen
AKA Kivelä
A Kivelä
ALAnna-liisa Levonen
Anna-liisa Levonen